Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference
Rhea-AI Summary
Medline (Nasdaq: MDLN) said CEO Jim Boyle and CFO Mike Drazin will present at the J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 3:00 PM PT.
The live presentation will stream on Medline’s investor events page at ir.medline.com, and a replay will be available on the same site for 30 days after the event.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, MDLN gained 0.19%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
No peer stocks with momentum or headlines were flagged, suggesting MDLN’s -4.83% move occurred without a broader sector signal.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 18 | Upsized IPO closing | Neutral | -3.7% | Closing of upsized IPO and use of proceeds for debt repayment and redemptions. |
The only recent news event, an upsized IPO, coincided with a negative next-day move, hinting at cautious early trading around capital markets events.
On Dec 18, 2025, Medline completed an upsized IPO, selling 248,439,654 Class A shares at $29.00, including 32,405,172 option shares. Proceeds from 179,000,000 shares were designated to repay senior secured term loan facilities, with additional shares used to purchase or redeem pre-IPO equity interests. The stock declined 3.66% after that event. Today’s announcement of participation in the J.P. Morgan Healthcare Conference marks a shift from capital-raising milestones to investor outreach and visibility activities.
Market Pulse Summary
This announcement highlights Medline’s upcoming presentation at the J.P. Morgan Healthcare Conference on January 13, 2026 at 3:00 pm Pacific Time, with a webcast replay available for 30 days. It follows the company’s recent upsized IPO at $29.00 per share, where proceeds were used partly to repay senior secured term loan facilities. Investors may focus on management’s commentary at the conference for additional clarity on strategy, capital allocation, and post-IPO priorities.
Key Terms
senior secured term loan facilities financial
Nasdaq Global Select Market financial
webcast technical
AI-generated analysis. Not financial advice.
NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on Tuesday, January 13, 2026, at 3:00 pm Pacific Time.
The presentation will be available on the Events page of Medline’s Investor Relations website at ir.medline.com. A replay of the webcast will be available on Medline’s Investor Relations website for 30 days following the event.
About Medline
Medline is the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs more than 43,000 people worldwide and operates in more than 100 countries. For more information, visit www.medline.com.
Contacts
Investor Relations:
Karen King
Global Head of Investor Relations
Patrick Flaherty
Director, Investor Relations
(847) 247-7222
IR@medline.com
Media Relations:
Ben Fox
Vice President, Corporate Communications
(224) 327-9999
media@medline.com
Source: Medline Inc.